Editorial
Welcome to the May 2012 homepage edition of i2P-Information to Pharmacists. Rollo Manning has been having some time out having staples removed from the site of his open heart surgery.He is now at home recuperating in Darwin, having arrived home last Friday, beating a cold and hasty retreat from Canberra.We all wish him a speedy recovery and hopefully, he will be fit enough to contribute by next month.
This month, Pharmedia discusses the toll that is taken when someone complains about you to an authority without good cause. Well, the good news is that you can now take action to protect yourself if such a complaint is made, and that may even include action for defamation. Read about a recent case involving two doctors, with Mark Coleman drawing on personal experience to illustrate.
Columns
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Harvey Mackay: Strategic Thinking
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4
EPublications
Sigma releases financial results
Printer-friendly version
Send to friend
PDF version | Staff Writer |
Editing and Researching news and stories about global and local Pharmacy Issues | |
Thursday afternoon, 31st March 2010.
Sigma has just released its long-awaited accounts disclosing a $389 million loss and a reduction in forecasted cash flows.
Despite the poor performance, Sigma claims its underlying business is sound and states that it has renegotiated its lines of finance.
The company has vowed to increase sales, cash flow and profitability, reduce extended terms of credit to some clients, reduce debt and improve inventory levels also selling non-core assets.
Most of Sigma’s client pharmacy accounts have been extremely loyal in past years, so it will be interesting to see whether that situation will remain firm.
For the moment its seems, CEO Elmo de Alwis will retain his job.
For all the background relating to Sigma and its problems click on this link.
Research Reports
Dr Richard Hallinan B Med FAChAM (RACP): X-Concord 2012 Seminar Summary - “Benzodiazepines and dependence”, with an emphasis on people on opioid pharmacotherapies | open full screen
Staff Researcher: Encouraging news for heart patientsPractice Development
Gerald Quigley: Don’t Give Up
Chris Foster: Seventeen Handy Tax Planning Tips for 2012
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Taking care of pharmacists’ health – what is it worth? | open full screen
Peter Sayers: The Climate Change in Evidence-based medicine
Neil Johnston: An Evidence-Based Conversation Between Ken Harvey, Gerald Quigley and Neil Johnston | open full screen
Neil Johnston: An Evidence-Based Conversation Between Ken Harvey, Gerald Quigley and Neil Johnston- Part 2 | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Tax time – a donation to PSS is a gift to your profession and a deduction for you | open full screen
Information Technology
Neil Retallick: Good news for community pharmacy from the Minister of Agriculture | open full screen
Dr Ian Colclough: While doctors remain disempowered doctor shoppers needing help will die. | open full screen
Dr David More: Australian Health Information Technology Links to 30 April 2012Preventive Medicine
If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Post new comment